AEON Biopharma, Inc.

AEON · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$13$5,158$9,746$5,128
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,577$1,064$92$26
Total Curr. Assets$1,590$6,222$9,838$5,154
Property Plant & Equip (Net)$1,523$594$906$922
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$29$29$34$360
Total NC Assets$1,552$623$940$1,282
Other Assets$0$0$0$0
Total Assets$3,142$6,845$10,778$6,436
Liabilities
Payables$5,910$3,388$7,805$1,192
Short-Term Debt$121$278$71,123$15,603
Tax Payable$569$569$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,549$8,814$3,646$4,009
Total Curr. Liab.$14,149$13,049$82,574$20,804
LT Debt$12,834$0$60,668$71,286
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,728$146,840$137,949$138,170
Total NC Liab.$17,562$146,840$198,617$209,456
Other Liabilities$0$0$0$0
Cap. Leases$1,266$278$499$524
Total Liabilities$31,711$159,889$281,191$230,260
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$14$14
Retained Earnings-$431,597-$473,602-$474,839-$422,283
AOCI$0$0$0$0
Other Equity$403,024$320,554$187,325$187,325
Total Equity-$28,569-$153,044-$287,500-$234,944
Supplemental Information
Minority Interest$0$0$17,087$11,120
Total Liab. & Tot. Equity$3,142$6,845$10,778$6,436
Net Debt$12,942-$4,880$122,045$81,761